Altimmune’s pemvidutide failed to significantly improve fibrosis in MASH patients in a Phase IIb study. The biotech crashed ...

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing ...

In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular, and massively lucrative in the last ...

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...

Even after dropping 1,300 bills to focus on the budget, the Florida Legislature passed more than 100 new laws that start July ...

More than 100 new laws will go into effect in Florida on July 1, with everything from animal abuse to education, state parks ...

The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly ...

Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a new study after hundreds of cases of acute and ...

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.